Cover Image
市場調查報告書

Desloratadine的中國市場分析 (2010∼2019年)

Investigation Report on China Desloratadine Market, 2010-2019

出版商 China Research and Intelligence 商品編碼 332768
出版日期 內容資訊 英文 30 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
Desloratadine的中國市場分析 (2010∼2019年) Investigation Report on China Desloratadine Market, 2010-2019
出版日期: 2015年06月11日 內容資訊: 英文 30 Pages
簡介

屬於抗組織胺藥物之一的Desloratadine,在2002年通過中國國內政府的核准而開始生產。之後市場便急速成長,2005年僅1200萬人民幣的市場規模,之後便以36%的年平均成長率(CAGR)成長,到2014年擴大到1億8500萬人民幣。田於中國近年來過敏性鼻炎的增加,一般認為今後市場仍將持續擴大。

本報告提供中國的Desloratadine的市場相關分析,提供您整體市場規模趨勢(過去5年份)和國內價格趨勢,各企業·投藥形態別的市場佔有率,主要製造商簡介,未來性的市場趨勢預測(今後5年份)等調查評估。

第1章 Desloratadine的相關概念

  • 症狀
  • 全球市場的銷售情形

第2章 中國的Desloratadine市場概況

  • 中國國內的Desloratadine專利的申請·認證情形
  • 主要製造商
  • 市場規模

第3章 Desloratadine銷售情形分析 (過去5年份)

  • 銷售額
    • 整體銷售額
    • 各地區的銷售額
  • 銷售量
    • 整體銷售量
    • 各地區的銷售量

第4章 中國的Desloratadine市場:主要廠商的市場佔有率分析 (過去5年份)

  • 市場佔有率 (以銷售額為準)
  • 市場佔有率 (以銷售量為準)

第5章 中國的Desloratadine市場:各劑型分析 (過去5年份)

  • 各劑型的市場佔有率 (以銷售額為準)
  • 各劑型的市場佔有率 (以銷售量為準)

第6章 Desloratadine的醫院用標準價格

  • Wante Pharmaceutical (Hainan) Co., Ltd
  • Schering-Plough (Italy)
  • Nanjing Hicin Pharmaceutical Co., Ltd
  • Hairui Pharmaceutical
  • Hainan Poly Pharm Co., Ltd
  • Shenzhen Salubris Pharmaceuticals Co., Ltd.
  • Shenzhen Haibin Pharmaceutical Co., Ltd

第7章 中國國內的Desloratadine的主要製造商

  • Hairui Pharmaceutical
  • Nanjing Hicin Pharmaceutical Co., Ltd
  • Shenzhen Haibin Pharmaceutical Co., Ltd
  • Shenzhen Salubris Pharmaceuticals Co., Ltd.
  • Hainan Poly Pharm Co., Ltd

第8章 中國的Desloratadine市場未來展望 (今後5年份)

  • 市場規模的預測
  • 競爭環境預測

圖表一覽

目錄
Product Code: 1506212

Histamine, a substance which can lead to inflammation and anaphylaxis, is one of the important chemical mediators of immediate anaphylaxis (the most common type I allergy in clinic). The incidence of allergy has always been high and shows an increasing trend. According to the American Acadymy of Allergy, Asthma and Immunology, allergy has become the sixth chronic disease in the US with 20%-40% of the total population suffering from it. According to the statistics, the number of cases of allergic rhinitis in China exceeds 100 million and the incidence of allergic disease has reached about 30%. For a long time, anti-histamine has been widely used for the desensitization treatment of allergic diseases especially allergic rhinitis and urticaria. Among all the patients with dermatosis in hospitals, those suffering from allergic dermatosis account for 30%. And 70% of them need anti-histamine, one representative of which is desloratadine. Developed by Sepracor and Schering-Plough, desloratadine first entered the British market in Feb. 2201 and has now become a top-selling drug in the world.

Local enterprises in China started developing the generic drugs of desloratadine early. In 2002, Hainan Poly Pharm Co., Ltd, Shenzhen Haibin Pharmaceutical Co., Ltd and Salubris were all approved by CFDA to produce desloratadine's Active Pharmaceutical Ingredients (APIs) and tablets. Desloratadine develops fast after entering China with annual sales value rising from less than CNY 12 million in 2005 to CNY 185 million in 2014 and CAGR reaching up to 36% during the period of 2005-2014. Desloratadine enjoys a vast demand in China. Hainan Poly Pharm Co., Ltd, Hairui Pharmaceutical, Nanjing Hicin Pharmaceutical Co., Ltd, Shenzhen Haibin Pharmaceutical Co., Ltd and Salubris all take up certain shares in the market, among which Hairui Pharmaceutical has the largest market share of over 55% in 2014 for sales value while Hainan Poly Pharm Co., Ltd has the largest market share of 32.3% for sales volume.

The market size of desloratadine in China is expected to keep growing in the next few years.

Readers can get at least the following information from this report:

  • market size of desloratadine in China
  • market share of manufacturers of desloratadine in China
  • price of desloratadine in Chinese market
  • major manufacturers of desloratadine in Chinese market
  • market outlook of desloratadine in China

The author suggests the following groups of people purchase this report:

  • manufacturers of anti-histammmines
  • investors/ research institutions interested in Chinese medicine market
  • any interest in the Chinese medicine market, please contact CRI for customized survey service

Table of Contents

1. Related Concepts of Desloratadine

  • 1.1. Indication
  • 1.2. Sales Status in Global Market

2. Market Profile of Desloratadine in China

  • 2.1. Patent and Approval Status of Desloratadine in China
  • 2.2. Major Manufacturers
  • 2.3. Market Size

3. Survey on Sales Status of Desloratadine in China, 2010-2014

  • 3.1. Sales Value
    • 3.1.1. Overall Sales Value
    • 3.1.2. Sales Value by Regions
  • 3.2. Sales Volume
    • 3.2.1. Overall Sales Volume
    • 3.2.2. Sales Volume by Regions

4. Survey on Market Share of Major Manufacturers of Desloratadine in China, 2010-2014

  • 4.1. Market Share by Sales Value
  • 4.2. Market Share by Sales Volume

5. Survey on Dosage Forms of Desloratadine in China, 2010-2014

  • 5.1. Share of Different Dosage Forms by Sales Value
  • 5.2. Share of Different Dosage Forms by Sales Volume

6. Reference Price of Desloratadine in Chinese Hospitals in 2014

  • 6.1. Wante Pharmaceutical (Hainan) Co., Ltd
  • 6.2. Schering-Plough (Italy)
  • 6.3. Nanjing Hicin Pharmaceutical Co., Ltd
  • 6.4. Hairui Pharmaceutical
  • 6.5. Hainan Poly Pharm Co., Ltd
  • 6.6. Shenzhen Salubris Pharmaceuticals Co., Ltd.
  • 6.7. Shenzhen Haibin Pharmaceutical Co., Ltd

7. Major Manufacturers of Desloratadine in Chinese Market, 2010-2014

  • 7.1. Hairui Pharmaceutical
  • 7.2. Nanjing Hicin Pharmaceutical Co., Ltd
  • 7.3. Shenzhen Haibin Pharmaceutical Co., Ltd
  • 7.4. Shenzhen Salubris Pharmaceuticals Co., Ltd.
  • 7.5. Hainan Poly Pharm Co., Ltd

8. Market Outlook of Desloratadine in China, 2015-2019

  • 8.1. Forecast of Market Size
  • 8.2. Forecast of Competitive Landscape

Selected Charts

  • Chart Patent Status of Desloratadine in China
  • Chart Approval Information of Desloratadine in China
  • Chart Sales Status of Desloratadine in China, 2010-2014
  • Chart Sales Value of Desloratadine in China, 2010-2014
  • Chart Sales Value of Desloratadine in Some Regions in China, 2010-2014
  • Chart Sales Volume of Desloratadine in China, 2010-2014
  • Chart Market Share of TOP5 Manufacturers of Desloratadine for Sales Value in China, 2010-2014
  • Chart Sales Value and Market Share of Desloratadine Made by Hairui in China, 2010-2014
  • Chart Sales Value and Market Share of Desloratadine Made by Nanjing Hicin in China, 2010-2014
  • Chart Sales Value and Market Share of Desloratadine Made by Hainan Poly in China, 2010-2014
  • Chart Sales Value and Market Share of Desloratadine Made by Salubris in China, 2010-2014
  • Chart Sales Value and Market Share of Desloratadine Made by Shenzhen Haibin in China, 2010-2014
  • Chart Sales Value and Market Share of Desloratadine Tablets in China, 2010-2014
  • Chart Sales Value and Market Share of Desloratadine Sirup in China, 2010-2014
  • Chart Sales Value and Market Share of Desloratadine Capsules in China, 2010-2014
  • Chart Sales Value and Market Share of Desloratadine Granules in China, 2010-2014
  • Chart Price of Desloratadine Made by Wante Pharmaceutical (Hainan) Co., Ltd in Some Chinese Cities in 2014
  • Chart Price of Desloratadine Made by Schering-Plough (Italy) in Some Chinese Cities in 2014
  • Chart Price of Desloratadine Made by Nanjing Hicin Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
  • Chart Price of Desloratadine Made by Hairui Pharmaceutical in Some Chinese Cities in 2014
  • Chart Price of Desloratadine Made by Hainan Poly Pharm Co., Ltd in Some Chinese Cities in 2014
  • Chart Price of Desloratadine Made by Salubris in Some Chinese Cities in 2014
  • Chart Price of Desloratadine Made by Shenzhen Haibin Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
Back to Top